Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients

Current Neurovascular Research

Volumn 7, Issue 1, 2010, Pages 1-5

  Staals, Julie ^a   Henskens, Léon H G ^a,b   Delanghe, Joris R ^c   Van Oostenbrugge, Robert J ^a,b   Kessels, Alfons G ^a   Kroon, Abraham A ^a,b   De Leeuw, Peter W ^a,b   Lodder, Jan ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cerebrovascular disease; Haptoglobin phenotype; Hypertension; Small vessel disease; White matter lesions

Indexed keywords

HAPTOGLOBIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BRAIN SIZE; CEREBRAL WHITE MATTER LESION; CEREBROVASCULAR DISEASE; DISEASE DURATION; ENDOTHELIUM INJURY; FEMALE; GEL ELECTROPHORESIS; GENE FREQUENCY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STROKE; WHITE MATTER;

EID: 77949687350     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720210790820163     Document Type: Article

References (30)

1. Donnan G, Norrving B, Bamford J, Bogousslavsky J. Subcortical stroke. New York: Oxford University Press 2002.
2. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34: 1126-9.
3. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005; 128: 2034-41.
4. de Leeuw F-E, de Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002; 125: 765-72.
5. Staals J, Pieters BMA, Knottnerus ILH, et al. Haptoglobin polymorphism and lacunar stroke. Curr Neurovasc Res 2008; 5: 153-8.
6. Van Vlierberghe H, Langlois M, Delanghe J. Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta 2004; 345: 35-42.
7. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996; 42: 1589-600.
8. Henskens LH, van Oostenbrugge RJ, Kroon AA, de Leeuw PW, Lodder J. Brain microbleeds are associated with ambulatory blood pressure levels in a hypertensive population. Hypertension 2008; 51: 62-8.
9. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis, a review. Stroke 1997; 28: 652-9.
10. Henskens LH, Kroon AA, van Oostenbrugge RJ, et al. Increased aortic pulse wave velocity is assocated with silent cerebral smallvessel disease in hypertensive patients. Hypertension 2008; 52: 1120-6.
11. Smithies O, Connell G, Dixon G. Inheritance of haptoglobin subtypes. Am J Hum Genet 1962; 14: 14-21.
12. Delanghe J, Cambier B, Langlois M, et al. Haptoglobin polymorphism, a genetic risk factor on coronary artery bypass surgery. Atherosclerosis 1997; 132: 215-9.
13. Delanghe J, Langlois M, Duprez D, de Buyzere M, Clement D. Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 1999; 145: 287-92.
14. Levy AP. Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy. Pharmacol Ther 2006; 112: 501-12.
15. Levy AP, Levy JE, Kalet-Litman S, et al. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 2007; 27: 134-40.
16. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-26.
17. Hassan A, Hunt BJ, O'Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126: 424-32.
18. Wardlaw JM, Sandercock PAG, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003; 34: 806-12.
19. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993; 91: 977-85.
20. Lohr NL, Warltier DC, Chilian WM, Weihrauch D. Haptoglobin expression and activity during coronary collateralization. Am J Physiol Heart Circ Physiol 2004; 288: H1389-95.
21. Rouhl RPW, van Oostenbrugge RJ, Damoiseaux JGMC, et al. Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease. Curr Neurovasc Res 2009; 6: 32-41.
22. Weinberger M, Miller J, Fineberg N, Luft F, Grim C, Christian J. Association of haptoglobin with sodium sensitivity and resistance of blood pressure. Hypertension 1987; 10: 443-6.
23. Delanghe J, Duprez D, de Buyzere M, et al. Haptoglobin polymorphism and complications in established essential arterial hypertension. J Hypertens 1993; 11: 861-7.
24. Depypere HT, Langlois MR, Delanghe JR, Temmerman M, Dhont M. Haptoglobin polymorphism in patients with preeclampsia. Clin Chem Lab Med 2006; 44: 924-8.
25. Gouw AA, van der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period. Stroke 2008; 39: 1414-20.
26. Delano-Wood L, Abeles N, Sacco JM, Wierenga CE, Horne NR, Bozoki A. Regional white matter pathology in mild cognitive impairment. Stroke 2008; 39: 794-9.
27. Sachdev P, Wen W. Should we distinguish between periventricular and deep white matter hyperintensities? Stroke 2005; 36: 2342-3.
28. Lazarus R, Prettyman R, Cherryman G. White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders. Int J Geriatr Psychiatry 2005; 20: 274-9.
29. Henskens LH, Kroon AA, van Boxtel MP, Hofman PA, de Leeuw PW. Associations of the angiotensin II type 1 receptor A1166C and the endothelial nitric oxide synthase G894T gene polymorphisms with silent subcortical white matter lesions in essential hypertension. Stroke 2005; 36: 1869-73.
30. de Leeuw F, Richard F, de Groot JC, et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 2004; 35: 1057-60.